This 1st gen CAR is constructed from an anti-CD138 scFv sequence fused with CD3ζ to successfully render NK92 cells with enhanced antitumor activity toward CD138-expressing MM cells, surprisingly unaffected by irradiation. The gene discussed is CD247; the disease is Miyoshi myopathy.